Collection of peripheral stem cells by apheresis is a welldescribed process. Here, investigations concerning 'agglutination and flocculation' of stem cells collected from two patients are described. In both cases, cryoproteins were observed and cryofibrinogen was identified using highresolution two-dimensional electrophoresis. In one case, peripheral stem cells were collected after a second course of mobilization, and the cells were immediately washed at 371C before being frozen, allowing their use, despite the presence of cryofibrinogen. In the other case, 'agglutination' was reversed by warming the bag, and plasma was removed before freezing.
stem cell collection; two-dimensional electrophoresis Haematopoietic stem cell transplantation, and more particularly autologous peripheral stem cell transplantation, is frequently used worldwide. 1 Collection procedures are well standardized, and protocols for quality assessment and clinical validation are available. However, many problems may occur after the cells have been collected, such as inadequate liquid nitrogen storage, leakage of the plastic bags during freezing-thawing, and bacterial or viral contamination in liquid nitrogen. We report an unexpected and unusual problem in two patients requiring autologuous stem cell transplantation.
Case report

Case 1
A 49-year-old patient with a 19-year-old history of transfusion-acquired hepatitis C and splenectomy presented in January 2003 with B symptoms and enlarged lymph nodes. Nodal and bone marrow biopsy revealed an aggressive large B-cell lymphoma with a component of marginal lymphoma, consistent with a stage IV transformed marginal lymphoma. Radiological exams showed an extensive epidural infiltration. The patient received four cycles of immuno-chemotherapy consisting of ACVBP combined with anti-CD20 (R-ACVBP), followed by one cycle of high-dose methotrexate. Peripheral stem cell collection was made in May 2003 following the fourth cycle of R-ACVBP, and cells were immediately cryopreserved in the presence of dimethylsulphoxide 10% (DMSO), in three different bags. By chance, the technician observed 'gel formation' of a sample taken from a bag, and kept in a test tube for 12 h at 41C. The search for cryoglobulins was negative in the serum. By contrast, a precipitate was observed after centrifugation of a plasma sample kept at 41C for 72 h (Figure 1a ). The plasma (Figure 1b ) and the cryoprecipitate ( Figure 1c) were studied by high-resolution two-dimensional electrophoresis (2-DE).
2 a, b and g chains of fibrinogen were found in the cryoprecipitate. One cryopreseved bag was thawed, and flocculation of the content was observed (Figure 1d ). Knowing that a cryofibrinogen was present, the bag was incubated at 371C, yet without disappearance of the aggregates. Washing the cells with a prewarmed washing solution of Normosol s (Abbott Laboratories, Chicago, IL, USA) was not successful, and a large agglomerate formed in the bag (Figure 1e) . A second stem cell mobilization was attempted (high-dose cyclophosphamide and G-CSF). The collected cells were immediately washed with prewarmed Normosol s (Figure 1f ), and frozen after the addition of DMSO. At transplantation, the thawed autologous stem cells were infused without any problem, and the clinical course of the patient was as expected.
Case 2
In January 2003, a 46-year-old man was diagnosed with multiple myeloma stage IA secreting kappa type light chains. He first presented in October 2002 with a myopathy due to histologically proven monoclonal immunoglobulin light chain deposition (AL amyloidosis). Chronic infections including hepatitis B, C and HIV as well as chronic autoimmune disorders were excluded. Because of organ (muscles, heart) involving AL amyloidosis, the patient was treated with three courses of VAD chemotherapy and planned for an autologous stem cell transplantation. After mobilization with vinorelbine and G-CSF, 3 the collection of haematopoietic stem cells was achieved without problems. But after the transport at 41C to the laboratory, the stem cell bag showed macroscopic red cell agglutination. With immediate rewarming of the bag to room temperature, agglutination disappeared suggesting the presence of cold agglutinins. The stem cells were washed at 371C with prewarmed PBS solution and frozen after addition of 10% DMSO and 10% human serum albumin. Thawing and infusion of autologous stem cells were uncomplicated, and engraftment occurred as expected after 11 days. Laboratory examination revealed the presence of a cryoprecipitate that was composed of a, b and g chains of fibrinogen mixed with IgM (Figure 2a ), which were more abundant when compared with the patient's plasma (Figure 2b ). In addition, 'cold agglutinins', with a restricted thermal amplitude, were identified in the serum. They reacted (2 þ ) with both group O adult or newborn red blood cells (the titer was 1/512). The direct antiglobulin test, including anti-C3d, was negative. The biochemical characterization of these 'cold agglutinins' was performed after cold absorption of the serum on red blood cells. After several cold washes with 0.15 M NaCl, red blood cells were warmed to 371C, and, after centrifugation, the supernatant was collected and studied using 2-DE. 4 As shown in Figure 2c , the eluted proteins were a mixture of polyclonal IgM with b and g chains of fibrinogen, without a chains. This mixture of proteins precipitated again upon cooling, and, the precipitate, after 2-DE analysis, was shown to be composed of the same peptides (Figure 2d ), these being almost completely absent from the supernatant (Figure 2e ).
Discussion
Cryoproteins are defined as proteins precipitating at low temperatures. Most frequently, the precipitate contains immunoglobulins (Igs), and are therefore called cryoglobulins. Three types of cryoglobulins have been described: type I contains a single monoclonal Ig, whereas type II is a mixture of a monoclonal Ig with polyclonal Igs, and type III is a mixture of polyclonal Igs of different isotypes, most frequently IgG and IgM. 5 Type II and type III are also called mixed cryoglobulins. A new type of cryoglobulins, containing polyclonal IgG associated with a mixture of polyclonal and monoclonal IgM, has been recently described. 2, 6, 7 In addition, proteins such as albumin 8 and fibrinogen 9 can also be observed as cryoproteins. Here, we present two cases of cryofibrinogenaemia highlighting the deleterious effect of cryoproteins when stem cells are collected and cooled before being cryopreserved. Although cryoglobulins are relatively frequently observed in patients with hepatitis C and haematological disorders, 10 the association between cryofibrinogen and lymphoma or myeloma has rarely been reported. 11, 12 A large series of 49 patients with cryofibrinogen was recently published. 9 The authors distinguished two categories of cryofibrinogen according to the absence or the presence of Igs in the precipitate. The association of cryofibrinogen with Igs appears to be an interesting phenomenon. In the laboratory work-up of the second case, cold agglutination of red cells as well as cryoproteins were detected. The 'cold agglutinins' were composed of polyclonal IgM, mixed with b and g chains of fibrinogen. Monoclonal IgM being both cold agglutinins and type II cryoglobulins have already been described, 7 but polyclonal IgM being both cold agglutinins and part of cryofibrinogen was an unexpected finding.
The phenomenon of gelling or of aggregating appears to be infrequent, and was observed in five out of 554 stem cell collections made over these last 54 months in Aarau and Lausanne. Unfortunately, in three cases, causative factors were not studied, and they were considered as process failures. However, as shown by this report, cryofibrinogen may be the cause of the problem, and, if undetected, may compromise the haematological stem cell support after administration of high-dose chemotherapy.
